Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Y Pappworth

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Virology|November 3, 2006
The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killingIsabel Y Pappworth, Eddie C Wang, Martin Rowe
Molecular Immunology|February 4, 2009
Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21)Isabel Y Pappworth, Liudmila Kulik, Catherine Haluszczak, et al.
Immunobiology|July 26, 2011
Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expressionIsabel Y Pappworth, Christine Hayes, Jason Dimmick, et al.
Molecular Immunology|April 11, 2009
Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type miceJason P Twohig, Isabel Y Pappworth, Baalasubramanian Sivasankar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infectionMaaike E Ressing, Sinéad E Keating, Daphne van Leeuwen, et al.
Cancers|September 9, 2022
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer TherapySantu Saha, Stuart Rundle, Ioannis C Kotsopoulos, et al.
Kidney International|July 30, 2015
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathyEva-Maria Nichols, Thomas D Barbour, Isabel Y Pappworth, et al.
Immunobiology|October 12, 2017
A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in miceYong-Gang He, Isabel Y Pappworth, Andreas Rossbach, et al.
Frontiers in Immunology|May 14, 2026
Properdin deficiency or anti-properdin treatment ameliorates disease in the C3 gain-of-function mouse model of atypical haemolytic uraemic syndromeGrace Mallett, Ola Kamala, Isabel Y Pappworth, et al.
Kidney International|January 23, 2025
The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndromeKate Smith-Jackson, Patrick Walsh, Wioleta M Zelek, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Virology|November 3, 2006
The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killingIsabel Y Pappworth, Eddie C Wang, Martin Rowe
Molecular Immunology|February 4, 2009
Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21)Isabel Y Pappworth, Liudmila Kulik, Catherine Haluszczak, et al.
Immunobiology|July 26, 2011
Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expressionIsabel Y Pappworth, Christine Hayes, Jason Dimmick, et al.
Molecular Immunology|April 11, 2009
Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type miceJason P Twohig, Isabel Y Pappworth, Baalasubramanian Sivasankar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infectionMaaike E Ressing, Sinéad E Keating, Daphne van Leeuwen, et al.
Cancers|September 9, 2022
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer TherapySantu Saha, Stuart Rundle, Ioannis C Kotsopoulos, et al.
Kidney International|July 30, 2015
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathyEva-Maria Nichols, Thomas D Barbour, Isabel Y Pappworth, et al.
Immunobiology|October 12, 2017
A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in miceYong-Gang He, Isabel Y Pappworth, Andreas Rossbach, et al.
Frontiers in Immunology|May 14, 2026
Properdin deficiency or anti-properdin treatment ameliorates disease in the C3 gain-of-function mouse model of atypical haemolytic uraemic syndromeGrace Mallett, Ola Kamala, Isabel Y Pappworth, et al.
Kidney International|January 23, 2025
The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndromeKate Smith-Jackson, Patrick Walsh, Wioleta M Zelek, et al.
Pageof 2